ORIGINAL PAPER
Atypical profile of intoxication with the mix of new psychoactive substances
More details
Hide details
1
Department of Infectious Diseases, Tropical Diseases and Hepatology, Medical University of Warsaw, Warsaw, Poland
2
Department of Paediatrics with Clinical Assessment Unit, Medical University of Warsaw, Warsaw, Poland
3
Department of Child and Adolescent Psychiatry, Institute of Psychiatry and Neurology, Warsaw, Poland
4
Department of Paediatrics, Prof. Jan Bogdanowicz Children’s Hospital, Warsaw, Poland
5
Chair and Department of Forensic Medicine, Wroclaw Medical University, Wroclaw, Poland
Submission date: 2019-11-05
Final revision date: 2019-12-26
Acceptance date: 2019-12-30
Publication date: 2019-12-31
Pediatr Pol 2019;94(6):351-356
KEYWORDS
TOPICS
ABSTRACT
Introduction:
In recent years an increase in the intake of new psychoactive substances (NPS) has been observed in the Polish adolescent population. Synthetic cathinones are a group of evolving drugs with stimulating, mind-altering effects. We report a case series of intentional intoxication with NPS and its atypical clinical course of poisoning.
Material and methods:
This study was approved by the Bioethical Committee of the Medical University of Warsaw (No. AKBE/166/2019). Clinical data of three adolescent patients intoxicated with NPS were admitted to two paediatric hospitals in Warsaw and retrospectively analysed. The composition of the preparation found in the patients was confirmed by the reference forensic laboratory. Analysed data from the medical records included: anthropometry, the route of poisoning, Glasgow Coma Scale (GCS), and Poisoning Severity Score (PSS) assessment, as well as the evaluation of vital signs and biochemistry of the peripheral blood.
Results:
All of the patients admitted that they had taken intranasally a designer drug called HEX-EN. The patients had disturbances of consciousness with a minimum of eight points in the Paediatric GCS. Two patients were aggressive. All of them developed hypotension and bradycardia at some point of hospitalisation. Moreover, all the patients had an affected respiratory system and muscle stiffness. Two of them had elevated creatine kinase serum level. Two patients showed features of liver damage. The nervous and muscular systems of all the patients were affected in at least a moderate grade. Toxicological analysis of white powder found on the inside walls of a plastic bag revealed a mix of cathinone derivatives: 3-CMC, N-ethylhexedrone (HEX-EN), synthetic cannabinoids, and caffeine.
Conclusions:
In most cases, the side effects of NPS result in consciousness disturbances, seizures, hyperthermia, hypertension, and tachycardia. Due to differences in composition and concentration of active substances contained in NPS products, intoxication symptoms are unpredictable and may require different symptomatic treatment.
REFERENCES (19)
1.
European Monitoring Centre for Drugs and Drug Addiction. European Drug Report 2019: Trends and Developments. Publications Office of the European Union, Luxembourg 2019: 1-100.
2.
Lista top „5”: Substancje psychoaktywne, najczęściej identyfikowane w zabezpieczanych przez organy Państwowej Inspekcji Sanitarnej, tzw. dopalaczach. April 18, 2018. Available at:
https://gis.gov.pl/zdrowie/sub... (accessed: 5 April 2019).
3.
Liu C, Jia W, Li T, et al. Identification and analytical characterization of nine synthetic cathinone derivatives N-ethylhexedrone, 4-Cl-pentedrone, 4-Cl-α-EAPP, propylone, N-ethylnorpentylone, 6-MeO-bk-MDMA, α-PiHP, 4-Cl-α-PHP, and 4-F-α-PHP. Drug Test Anal 2017; 9: 1162-1171.
4.
Simmons SJ, Leyrer-Jackson JM, Oliver CF, et al. DARK Classics in Chemical Neuroscience: Cathinone-Derived Psychostimulants. ACS Chem Neurosci 2018; 9: 2379-2394.
5.
Majchrzak M, Celiński R, Kuś P, et al. The newest cathinone derivatives as designer drugs: an analytical and toxicological review. Forensic Toxicol 2018; 36: 33-50.
6.
Carroll FI, Lewin AH, Mascarella SW, et al. Designer drugs: a medicinal chemistry perspective. Ann N Y Acad Sci 2012; 1248: 18-38.
7.
Mikołajczyk A, Adamowicz P, Tokarczyk B, et al. Determination of N-ethylhexedrone, a new cathinone derivative, in blood collected from drivers – analysis of three cases. Z Zag Nauk Sąd 2017; 109: 65-82.
9.
Kelly JP. Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. Drug Test Anal 2011; 3: 439-453.
13.
Karch SB. Cathinone Neurotoxicity (“The “3Ms”). Curr Neuropharmacol 2015; 13: 21-25.
15.
Prosser JM, Nelson LS. The Toxicology of Bath Salts: A Review of Synthetic Cathinones. J Med Toxicol 2012; 8: 33-42.
16.
German CL, Fleckenstein AE, Hanson GR. Bath salts and synthetic cathinones: An emerging designer drug phenomenon. Life Sci 2014; 97: 2-8.
17.
Adamowicz P, Gieroń J. Acute intoxication of four individuals following use of the synthetic cannabinoid MAB-CHMINACA. Clin Toxicol (Phila) 2016; 54: 650-654.
18.
Persson HE, Sjöberg GK, Haines JA. Poisoning severity score. Grading of acute poisoning. J Toxicol Clin Toxicol 1998; 36: 205-213.
19.
Ghuran A, Nolan J. The cardiac complications of recreational drug use. West J Med 2000; 173: 412-415.